Nisa Investment Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.43K | Sell |
850
-808
| -49% | -$6.11K | ﹤0.01% | 2403 |
|
2025
Q1 | $9.15K | Buy |
1,658
+1,123
| +210% | +$6.2K | ﹤0.01% | 2120 |
|
2024
Q4 | $3.08K | Sell |
535
-2,292
| -81% | -$13.2K | ﹤0.01% | 2383 |
|
2024
Q3 | $29.3K | Sell |
2,827
-59
| -2% | -$611 | ﹤0.01% | 1784 |
|
2024
Q2 | $37.4K | Buy |
2,886
+59
| +2% | +$765 | ﹤0.01% | 1743 |
|
2024
Q1 | $49.4K | Hold |
2,827
| – | – | ﹤0.01% | 1658 |
|
2023
Q4 | $26.6K | Buy |
2,827
+2,281
| +418% | +$21.5K | ﹤0.01% | 1790 |
|
2023
Q3 | $6.1K | Buy |
546
+36
| +7% | +$402 | ﹤0.01% | 2266 |
|
2023
Q2 | $10.9K | Buy |
510
+333
| +188% | +$7.13K | ﹤0.01% | 2243 |
|
2023
Q1 | $7K | Sell |
177
-750
| -81% | -$29.7K | ﹤0.01% | 2202 |
|
2022
Q4 | $43K | Sell |
927
-9
| -1% | -$417 | ﹤0.01% | 1824 |
|
2022
Q3 | $42K | Sell |
936
-271
| -22% | -$12.2K | ﹤0.01% | 1805 |
|
2022
Q2 | $57K | Buy |
1,207
+750
| +164% | +$35.4K | ﹤0.01% | 1692 |
|
2022
Q1 | $33K | Sell |
457
-1,077
| -70% | -$77.8K | ﹤0.01% | 1943 |
|
2021
Q4 | $91K | Sell |
1,534
-2,886
| -65% | -$171K | ﹤0.01% | 1546 |
|
2021
Q3 | $251 | Sell |
4,420
-2,014
| -31% | -$114 | ﹤0.01% | 1328 |
|
2021
Q2 | $283 | Hold |
6,434
| – | – | ﹤0.01% | 1298 |
|
2021
Q1 | $317 | Hold |
6,434
| – | – | ﹤0.01% | 1317 |
|
2020
Q4 | $271K | Buy |
6,434
+2,762
| +75% | +$116K | ﹤0.01% | 1355 |
|
2020
Q3 | $168K | Buy |
3,672
+3,032
| +474% | +$139K | ﹤0.01% | 1369 |
|
2020
Q2 | $32K | Buy |
640
+500
| +357% | +$25K | ﹤0.01% | 1672 |
|
2020
Q1 | $7K | Buy |
140
+50
| +56% | +$2.5K | ﹤0.01% | 1904 |
|
2019
Q4 | $6K | Hold |
90
| – | – | ﹤0.01% | 1909 |
|
2019
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 1895 |
|
2019
Q2 | $8K | Hold |
90
| – | – | ﹤0.01% | 1807 |
|
2019
Q1 | $9K | Hold |
90
| – | – | ﹤0.01% | 1780 |
|
2018
Q4 | $6K | Hold |
90
| – | – | ﹤0.01% | 1761 |
|
2018
Q3 | $8K | Buy |
+90
| New | +$8K | ﹤0.01% | 1779 |
|